DIN 02046121 — TEVA-CLONIDINE 0.1 MG
TEVA-CLONIDINE is a tablet of Clonidine marketed by TEVA CANADA LIMITED. The full Clonidine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02046121
- Brand name
- TEVA-CLONIDINE
- Active ingredient
- Clonidine
- Strength
- 0.1 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Centrally acting alpha-2 adrenergic agonist (antihypertensive)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Clonidine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02540061 | CLONIDINE | 0.025 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02538490 | CLONIDINE | 0.1 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02538504 | CLONIDINE | 0.2 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02528207 | JAMP CLONIDINE | 0.025 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02524198 | MAR-CLONIDINE | 0.025 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED |
| 02534738 | MINT-CLONIDINE | 0.025 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02462192 | MINT-CLONIDINE | 0.1 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02462206 | MINT-CLONIDINE | 0.2 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02516217 | SANDOZ CLONIDINE | 0.025 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02515784 | SANDOZ CLONIDINE | 0.1 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02515792 | SANDOZ CLONIDINE | 0.2 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02304163 | TEVA-CLONIDINE | 0.025 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02046148 | TEVA-CLONIDINE | 0.2 MG | TABLET | TEVA CANADA LIMITED | MARKETED |